Image source: Getty Images.
Continue Reading Below
This morning, Adeptus Health rescheduled its planned third-quarter earnings release from this morning to after the closing bell this afternoon. As a result, it has also rescheduled its conference call from 10 a.m. to 5 p.m. EDT today.Since no reason was provided for the delay, investors are left to do their own guesswork, and that kind of uncertainty never bodes well for a company's stock price. Adding to the uncertainty is a recent track record of delivering less-than-welcome news.
Shares sold off sharply following second-quarter results, which missed estimates. Recently, the stock dropped following news that longtime CEO Thomas S. Hall is leaving early next year.
Current guidance is forsales of between $640 million to $670 million and adjusted earnings per share of at least $2.55 in 2016. However, that guidance could change depending on the company's third-quarter performance.
While Adeptus Health's shares can be bought cheaper now than yesterday, investors are probably best served by waiting until the report is out and an explanation for the delay is given before considering whether to buy in.
A secret billion-dollar stock opportunity The world's biggest tech company forgot to show you something, but a few Wall Street analysts and the Fool didn't miss a beat: There's a small company that's powering their brand-new gadgets and the coming revolution in technology. And we think its stock price has nearly unlimited room to run for early in-the-know investors! To be one of them, just click here.
Todd Campbell has no position in any stocks mentioned.Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may have positions in the companies mentioned.Like this article? Follow him onTwitter where he goes by the handle@ebcapitalto see more articles like this.
The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.